STEP 2

What is STEP 2?

STEP 2 put semaglutide 2.4 mg to work in people carrying both excess weight and type 2 diabetes (Davies et al., Lancet 2021).

Body weight came down 9.6% by week 68 against 3.4% on placebo, and HbA1c dropped 1.6 points. Wegovy's use in a diabetic population rests on this trial.

Related reading: STEP-2: Semaglutide With Type 2 Diabetes

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.

Where STEP 2 comes up on this site

On GLP Watchdog, STEP 2 comes up in 1 research article.

Other terms under trial

• SURMOUNT-5
• SURMOUNT-2
• SURMOUNT-3
• SURPASS-2
• SUSTAIN-6
• REWIND
• PIONEER 6
• STEP-HFpEF
• EXSCEL
• ELIXA
• AMPLITUDE-O
• HARMONY OUTCOMES
• SCALE Diabetes
• SUMMIT
• SCALE Maintenance

Where the evidence lives

• The full GLP-1 glossary (150 terms, 8 categories)
• Research articles — written from primary sources
• Tools and calculators
• Compare GLP-1 telehealth providers